How have GANX and LUNG total returns compared?

Over the past 5 years, GANX delivered -25.06% and LUNG delivered -45.30% annualized total return. Past performance doesn't predict future results.

Gain Therapeutics, Inc. (GANX) vs Pulmonx Corporation (LUNG)

A side-by-side comparison of Gain Therapeutics, Inc. and Pulmonx Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

GANX

Gain Therapeutics, Inc.

$72M

$1.70HealthcareDelayed quote: Oct 6, 2026, 2:42 PM EDT

LUNG

Pulmonx Corporation

$76M

$1.80HealthcareDelayed quote: Oct 6, 2026, 2:45 PM EDT

Total return — GANX vs LUNG

growth of $100 · dividends reinvested · last 6y

GANX -84.9% (-27.0%/yr)LUNG -96.9% (-43.8%/yr)GANX compounded faster over this window

GANX LUNG

GANX vs LUNG: by the numbers

•LUNG is the larger company ($76M vs $72M market cap).
•Both run net losses; GANX's is the smaller (0.00% vs -55.03% net margin).

Metrics side by side

Valuation

Metric	GANX	LUNG
P/S ratio	N/A	0.87
P/B ratio	6.40	1.93

Profitability

Metric	GANX	LUNG
Gross margin	0.00%	77.06%
Operating margin	0.00%	-52.96%
Net margin	0.00%	-55.03%
ROE	-178.06%	-122.76%
ROIC	-159.24%	-48.39%

Growth (annualized)

Metric	GANX	LUNG
Revenue CAGR (5Y)	N/A	15.86%
Total return CAGR (5Y)	-25.06%	-45.30%

Frequently asked

How have GANX and LUNG total returns compared?: Over the past 5 years, GANX delivered -25.06% and LUNG delivered -45.30% annualized total return. Past performance doesn't predict future results.

Go deeper

Full GANX analysis Full LUNG analysis Interactive comparison tool

Dig into the metrics

Gain Therapeutics ROE Pulmonx ROE Gain Therapeutics operating margin Pulmonx operating margin Gain Therapeutics revenue growth Pulmonx revenue growth Gain Therapeutics free cash flow Pulmonx free cash flow

Gain Therapeutics & Pulmonx appear in these rankings

Fastest Revenue Growth Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.